Gene Query: MTFR1L

Dataset Description Geneva Score
Transcriptome analysis of immature and matured human oocytes from patients of young and advanced maternal age 24.59
yylncT acts as a gatekeeper of the mesodermal transcriptional program by local modulation of DNMT3B [human_2] 18.3
Gene expression analysis of immortalized human liver progenitor-like cells in culture 17.65
Episomal HBV persistence within transcribed host nuclear chromatin compartments involves HBx 17.27
Nutritional control of protein translation 14.9
Transcriptome analysis of U87 cells upon LINC00152 knockdown 14.79
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 14.14
IL-11 neutralising therapies for the treatment of nonalcoholic steatohepatitis 12.98
A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities. 12.72
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 12.4
RNA-seq of IL-4 stimulated human keratinocytes 12.12
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells 11.53
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells [RNA-seq] 11.53
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression [RNA-Seq] 10.93
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression 10.93
Molecular mechanism underlying increased ischemic damage in the ALDH2*2 genetic polymorphism using a human iPSC model system 10.82
Targeting MTHFD2 in Acute Myeloid Leukemia 9.49
Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection 9.48
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer [RNA-Seq] 9.39
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer 9.39
MicroRNA (miR)-211 loss promotes metabolic vulnerability and BRAF inhibitor sensitivity in melanoma 9.36
REPROGRAMMING IDENTIFIES FUNCTIONALLY DISTINCT STAGES OF CLONAL EVOLUTION IN MYELODYSPLASTIC SYNDROMES 9.36
DNA Methylation Reprograms Metabolic Gene Expression in End-Stage Human Heart Failure 9.06
Expression by CD133+ cells isolated from the adult human exocrine pancreas 8.63
Cell responses to dysregulated VZV-induced cell-cell fusion 8.59
Derivation of ventrical and atrial cardiomyocytes and maturation using biowires 7.88
Understanding the reproducibility and robustness of the kidney organoid differentiation protocol using RNA-seq 7.7
Genome-wide transcriptome analysis of NIPBL iPSC and commited cardiomyoctes 7.52
Genome-wide profiling of siRNA targeting EWS-FLI1 in TC32 Ewing sarcoma cell line 7.49
Enhancing human kidney organoid differentiation from pluripotent stem cells with high-throughput automation 7.45
Transcriptomic analysis of cultured corneal endothelial cells as a validation for their use in cell-replacement therapy 7.36
RNA-seq of MDA-MB-231 cells with TET1 knockout 7.23
Convergent exaptation of Alu and B/ID SINEs for Staufen-mediated mRNA decay 7.14
Quantitative comparison between cellular mRNAs and exosomal mRNAs in human iPSC-derived motor neurons 7.06
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA-Seq] 6.99
Primary human trophoblast from term placenta 6.86
An optimization system for isolating and sequencing of single human colon cancer cells 6.74
CENPA-Bound Genes and Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cells 6.72
Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cell Lines 6.72
Epigenetic siRNA and chemical screens identify SETD8 inhibition as a new therapeutic strategy of p53 reactivation in high-risk Neuroblastoma. 6.67
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 6.63
P120-catenin dependent glioma-cell networks drive growth and diffuse brain infiltration 6.63
Transcription elongation factors are in vivo-specific cancer dependencies in glioma 6.6
RNA-seq Profiles in Transcription elongation factors are in vivo-specific cancer dependencies in glioma 6.6
An aspartyl protease defines a novel pathway for export of Toxoplasma proteins into the host cell 6.6
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile [mRNA-Seq] 6.44
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile 6.44
Regulation of cellular heterogeneity and rates of symmetric and asymmetric divisions in triple-negative breast cancer 6.42
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 6.41
Essential Roles of SETD7 as Transcriptional Activator and Co-regulator of H3K36me in Cardiac Lineage Commitment 6.32
Kidney organoid reproducibility across multiple human iPSC lines and diminished off target cells after transplantation revealed by single cell transcriptomics 6.16
CD97 is a Critical Regulator of Acute Myeloid Leukemia Stem Cell Function 6.12
EWSR1 influences alternative splicing through direct and indirect mechanisms 6.03
RNA-seq differential expression studies: more sequence, or more replication? 6.0
Transcriptomic analysis of the effect of trastuzumab in human iPSC-CMs 5.96
TRIM24 is an oncogenic transcriptional co-activator of STAT3 in glioblastoma 5.95
Dual role of CSL (RBP-Jk) and NOTCH1 in CAF 5.94
Dual role of CSL (RBP-Jk) and NOTCH1 in cancer-associated fibroblast genome stability and expansion [RNA-seq] 5.94
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury [human iPS] 5.93
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury 5.93
Evaluating pre-clinical models for studying NASH driven HCC. 5.9
A potent and selective small-molecule degrader of STAT3 achieves complete tumor regression in vivo 5.85
RNASeq of MV4;11 cells transduced with scramble shRNA or BRD4 shRNA in combination with DMSO or SGC0946 5.84
Transcriptome-wide identification of CELF2 functional targets in T cells 5.82
Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 5.74
Human CD11b+ macrophages - Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 5.74
RNAseq of PRMT4KD in human cord blood derived CD34+ cells 5.71
Distinct regulation of alternative polyadenylation and gene expression by nuclear poly(A) polymerases 5.67
Dynamic reorganization of nuclear architecture during human cardiogenesis [RNA-seq] 5.64
Dynamic reorganization of nuclear architecture during human cardiogenesis 5.64
Total RNA sequencing of prospective axial stem cell cultures derived from human pluripotant stem cells 5.63
HEK293 TFAM Knockout Expression Study 5.62
RNASeq of Healthy Human Skin Tregs and CD4 Teffs versus Psoriatic Human Skin Tregs and CD4 Teffs 5.6
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [IMR90_MCF7_RNA-Seq] 5.47
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone 5.47
RNA expression analysis of neuroblastoma cell lines treated with epigenetic drugs 5.42
RNAseq analysis of the human neutrophil transcriptome, with and without in vitro cytokine stimulation 5.41
Identification of the networks that regulate human monocytic myeloid-derived suppressor cell differentiation into inflammatory macrophages 5.34
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 5.32
Stem and effector CD8 T-cells from human cancers 5.27
RNA-sequencing of human liver tissue 5.24
A role for ZNF598 in post-transcriptional gene regulation 5.21
DART-seq: an antibody-free method for global m6A detection 5.21
4sUDRB-seq: measuring transcription elongation and initiation genomewide 5.17
The pause-initiation limit restricts transcription activation in human cells 5.17
IGF2BP3 controls cancer cell invasiveness by modulation RISC function 5.14
Obstructed defecation – an enteric neuropathy? An exploratory study of patient samples 5.09
UV-Irradiation Induces a Noncoding RNA that Functionally Opposes the Protein Encoded by the Same Gene 5.07
Single-Cell reconstruction of differentiation trajectory reveals essential dynamics in human cardiac lineage commitment 5.05
RNA-seq analysis of control and ZC3H18-depleted ovarian cancer cells 4.91
Transcriptomic and gene ontology profiling of the human corneal cell types 4.9
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq2] 4.9
Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells 4.89
Integrative Genomic Analysis Reveals Widespread Enhancer Regulation by p53 in Response to DNA Damage 4.86
Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma 4.85
Transcriptional profiling identifies differential expression of long non-coding RNAs in Jo-1 associated and inclusion body myositis 4.83
Epigenomic landscape during organ formation in human early embryos 4.8
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 4.64
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 4.63
Synergy from Gene Expression and Network Mining (SynGeNet) method predicts genotype-specific synergistic drug combinations in melanoma 4.59
SUV420H2 knockdown in PANC-1 4.57
Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence 4.56
Chronic cadmium exposure decreases the dependency of MCF7 breast cancer cells on ERα 4.54
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [RNA-seq] 4.53
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer 4.49
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer [RNA-seq] 4.49
Homolog-selective degradation as a strategy to probe the function of CDK6 in AML 4.43
HNF1 regulates critical functions of the human epididymis epithelium. [RNA-Seq] 4.43
HNF1 regulates critical functions of the human epididymis epithelium. 4.43
Global Gene Expression analysis of CUTLL1 cell lines after treatment with Perhexiline 4.43
Activation of a SOX2-dependent transcriptional regulatory circuit drives glioblastoma. 4.42
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 4.42
Hyper-excitability of Neurons generated from Patients with Bipolar Disorder 4.4
PTBP1 excludes UPF1 to protect long 3'UTRs from nonsense-mediated mRNA decay 4.37
Comprehensive comparative analysis of 5’ end RNA sequencing methods 4.3
Transcriptome analysis of genetically matched human induced pluripotent stem cells disomic or trisomic for chromosome 21 4.29
Exercise-induced transcriptome changes in skeletal muscle adapted to aerobic training 4.28
Next-generation RNA sequencing to determine changes in gene expression during breast cancer progression 4.26
GREB1 amplifies androgen receptor output in prostate cancer and contributes to antiandrogen resistance 4.25
C9orf72 Intermediate Repeats are Associated with Corticobasal Degeneration, Increased C9orf72 Expression and Disruption of Autophagy 4.24
A pooled single-cell genetic screen identifies regulatory barriers in the continuum of the epithelial-to-mesenchymal transition 4.24
Human iPSC derived glomeruli facilitate accurate modelling of podocytopathy 4.24
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 4.14
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 4.14
Triplet nucleotide repeat-based siRNAs are highly toxic to cancer cells 4.05
Identification of the O-GlcNAc-regulated alternative splicing events by performing RNA sequencing on HeLa cells with altered O-GlcNAc level. 4.04
Analysis of the polyA+ RNA of LPS-treated human CD14+ monocytes 4.02
A role for p53 in the adaptation to glutamine starvation through the expression of Slc1a3 4.01
RNA-seq of UGP2 mutant human embryonic stem cells and in vitro differentiated neural stem cells 4.01
RNA sequencing for human induced pluripotent stem cell cardiomyocyte differentiation 3.99
Altering cancer transcriptomes using epigenomic inhibitors 3.97
Altering cancer transcriptomes using epigenomic inhibitors [RNA-Seq] 3.97
Dual modulation of neuron specific microRNAs and the REST complex promotes functional maturation of induced human adult neurons 3.95
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis 3.94
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis [RNA-Seq] 3.94
Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids 3.93
Transciptomic profiling of human fetal lung samples 3.92
Glioma Stem Cell Specific Super Enhancer Drives Polyunsaturated Fatty Acid Synthesis to Support EGFR Signaling 3.92
Human MAIT cells exit peripheral tissues and re-circulate via lymph in steady state conditions 3.92
The m 6 A-methylase complex recruits TREX and regulates mRNA export. 3.91
Novel Transcriptional Activity and Extensive Allelic Imbalance in the Human MHC Region 3.89
Detailed genomic and molecular characterization of Indian induced pluripotent stem cell lines 3.86
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation 3.85
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation (RNA-Seq) 3.85
The evolution of N6-methyladenosine in primates 3.84
CD13 and ROR2 permit isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 3.83
Isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 3.83
RNA-seq of tumor cells following angiopellosis extravasation 3.83
mRNA-sequencing of 293T-no dice transfected with miR-16, miR-214, or KSHV-miR-K6-5p 3.79
Effect of mitochondria deficiency on senescence-associated gene expression 3.78
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 3.77
Tamoxifen Resistance in Breast Cancer is Regulated by the EZH2-ERa-GREB1 Transcriptional Axis 3.73
Major hnRNP proteins act as general TDP-43 functional modifiers both in Drosophila and human neuronal cells. 3.71
Transcriptional Modulation of Human Endogenous Retroviruses in Primary CD4+ T Cells Following Vorinostat Treatment 3.7
Transcriptome of human white and brown adipose tissue biopsies 3.68
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 3.67
Gene expression changes in HSV-1 infected HeLa cells with knockdown of B2M 3.67
The regulartory role of ZCCHC24 in splicing machinery 3.64
Effect of BRCA1 overexpression on genetic expressions of cervical cancer based on next generation sequencing 3.64
Pitfalls in Single Clone CRISPR-Cas9 Mutagenesis to Fine-map Regulatory Intervals 3.62
A rare subpopulation of melanoma cells with low expression of metastasis suppressor NME1 has a neural crest-like phenotype and is highly metastatic in vivo 3.6
RNA-Seq analysis of human lung fibroblasts exposed to TGF-β 3.6
The DNM3OS lncRNA is a reservoir of fibromiRs with major functions in fibroblast response to TGF-beta and fibrogenesis 3.6
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 3.58
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 3.58
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 3.58
Genome-wide Analysis of Human Constitutive Androstane Receptor (CAR) Transcriptome in Wild-type and CAR-knockout HepaRG cells 3.58
Splicing towards noncoding isoforms in colorectal carcinoma is associated with tumor hypoxia and the DNA damage response 3.57
Estrogen response in breast cancer cell line MCF-7 is dependent on NR2F2 [RNA-seq] 3.56
NR2F2 study 3.56
Novel mutations segregating with Complete Androgen Insensitivity Syndrome and their molecular characteristics. 3.56
RNA-seq analysis of the human fetal kidney. 3.55
Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance [RNA-seq] 3.55
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network with PRC2 [RNA-seq] 3.55
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network 3.55
Robust generation of honemogeneous midbrain organoids with in vivo–like cellular composition facilitates neurotoxin-based Parkinson’s disease modeling 3.55
Examining serotonergic neuron differentiation from human iPSCs 3.51
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex 3.5
Estrogen deprivation triggers and immunosuppressive phenotype in breast cancer cells 3.47
mRNA expression in human DAOY cells 3.45
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 3.44
Cooperation of dominant oncogenes with regulatory variants shapes clinical outcomes in pediatric cancer 3.43
RNA-seq of three Ewing sarcoma cell lines (A673, SK-N-MC, RDES), transfected with either siControl or siMYBL2. 3.43
X-Ray induced DNA-Hydroxymethylation changes 3.42
Identifying lincRNA as prognostic biomarker for clear cell renal cell carcinoma 3.38
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium 3.35
Transcriptome of EMT induced MCF10A cells by TGFb treatment or SNAIL S6A expression. 3.32
Transcriptome sequencing of human coronary artery smooth muscle cell under treatment of nitrated fatty acid 3.3
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [K562] 3.3
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability 3.29
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (22RV1 RNA-seq) 3.29
RNA-seq of HDAC2-disrupted 293FT cells by CRISPR-Cas9 3.28
Global analysis of enhancer targets: Mosaic-seq 3.27
Gene Expression Analysis of Melanoma Cells Treated with 6-Thio-dG In Vitro 3.26
RNA expression profiling of human mPB or CB-derived CD34+ cells treated with UM171 at different doses 3.26
Hijacking of stress response machinery by oncogenes in acute leukaemia [RNA-seq] 3.23
Hijacking of stress response machinery by oncogenes in acute leukaemia 3.23
Characterization of human ILC2 subsets 3.22
Metformin induces chromosome reorganization and changes in gene expression in normal human fibroblasts 3.22
Gene expression and chromatin organization changes in lamin A/C haploinsufficient human induced pluripotent stem cell-derived cardiomyocytes 3.21
Gene expression and chromatin organization changes in lamin A/C haploinsufficient human induced pluripotent stem cell-derived cardiomyocytes [RNA-seq] 3.21
Transcriptional effect of ETV1 knockdown in melanoma cells 3.21
Trans-differentiation of human adult peripheral blood T cells into neurons 3.21
SIRT6 regulates redox homeostasis in human mesenchymal stem cells by the transactivation of NRF2 3.18
Gene expression in GBM with Cav3.2 inhibition 3.17
Gene expression in skeletal muscle in older individuals subject to ten days of complete bed rest. 3.16
Gene expression profile in endometrial organoids cultured in normal follicular phase vs PCOS-like hormone profile 3.15
DRB/GRO-Seq -/+ UV 3.15
Isolation and sequencing of AGO-bound RNAs reveals characteristics of stem-loop processing in vivo 3.12
Unraveling cis-regulatory elements by mapping structural changes in mRNAs 3.12
mRNA-seq from Nutlin-3a, doxorubicin, and DMSO treated HCT116 p21-/- cells 3.11
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 3.1
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure or Aurora kinase inhibition [tpo3] 3.09
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 3.08
The effect of Abl kinases on non-small cell carcinoma global transcriptome 3.03
Transcriptome of U251 cells overexpression complement component 7 3.02
Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging 3.01
Sauchinone controls hepatic cholesterol homeostasis by the negative regulation of PCSK9 transcriptional network 2.99
Human Long Intergenic Noncoding RNA Linc-ADAL Knockdown in Mature Adipocytes using Lentiviral ShRNA 2.99
Non-coding and coding transcriptional profiles are significantly altered in pediatric Retinoblastoma tumors 2.99
AKAP8 inhibits tumor metastasis by antagonizing EMT-associated RNA alternative splicing 2.98
A Stable Transcription Factor Complex Nucleated by Dimeric AML1-ETO Controls Leukaemogenesis 2.97
Identification of Atrial Fibrillation associated genes and functional non-coding variants 2.95
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer 2.94
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer [RNA-Seq] 2.94
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming 2.91
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming (RNA-seq fibroblasts) 2.91
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma (RNA-Seq) 2.9
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma 2.9
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 2.86
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 2.86
Next generation sequencing analysis of transcriptomes at different timepoints after chlorprothixene treatment in NB4 and Kasumi-1 cells 2.8
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 2.8
Genetic-to-epigenetic Therapy for Pancreatic Cancer 2.79
Transcription control by the ENL YEATS domain in acute leukemia [RNA-seq] 2.73
Transcription control by the ENL YEATS domain in acute leukemia 2.73
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 2.68
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG 2.68
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG [RNA-seq] 2.68
RNA-Seq study of Cell lines rendered resistant to idelalisib and ibrutinib 2.68
Controlling for gene expression changes in transcription factor protein networks. 2.66
Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of BET inhibitor JQ1 2.66
Compensatory Csf2-driven macrophage activation blunts long-term efficacy of therapeutic Csf1r inhibition in breast-to-brain metastasis 2.65
AhR activity directs BRAF inhibitors resistance in metastastic melanoma 2.65
Effects of NSUN2 deficiency on the mRNA 5-methylcytosine modification and gene expression profile in HEK293 cells (RNA-Seq) 2.65
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 2.6
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer 2.6
Acquired resistance to MEK-CDK4/6 inhibitor combinations in cutaneous melanoma 2.59
Differential YAP expression in glioma cells induces cell competition and promotes tumorigenesis 2.56
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 2.56
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 2.56
Functional Cardiac Fibroblasts Derived from Human Pluripotent Stem Cells via Second Heart Field Progenitors 2.54
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations [RNA-seq] 2.54
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations 2.54
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1, H1 derived APLNR+ cells, CD31+CD34+ cells and CD43+ cells during human early hematopoietic differentiation 2.52
Activity-dependent transcriptional changes in human neurons 2.52
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 2.47
Analysis of transcriptome changes following SOX2 knockdown in three different Ewing sarcoma cell lines 2.47
Nucleotide excision repair capacity increases during differentiation of human embryonic carcinoma cells into neurons and muscle cells 2.45
Diarrhoeal mechanisms of the Campylobacter jejuni enteritis 2.45
Impact of Escherichia coli K12 and O18 on human platelets: effects on platelet activation, spliced platelet RNAs and proteins 2.44
SMUG1 promotes telomere maintenance through telomerase RNA end-processing 2.44
Prolyl hydroxylation regulates protein degradation, synthesis, and splicing in human induced pluripotent stem cell-derived cardiomyocytes 2.43
Expression profiles of cultured human epididymis cells reveal the functional diversity of caput, corpus and cauda regions. 2.38
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (BGI12 RNA-Seq) 2.37
RNA sequencing based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers 2.37
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 2.36
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 2.36
Ribosome profiling of TGFb-treated cells indicates reduced leucine availability 2.36
Tyrosine Kinase Inhibitor Cardiotoxicity 2.32
High-Throughput Screening of Human Induced Pluripotent Stem Cell Cardiomyocytes Predicts Tyrosine Kinase Inhibitor Cardiotoxicity 2.32
ChIP-seq and RNA-seq analysis of KMT2D-silenced metastatic melanoma cells 2.31
RNA-Seq in neutrophils from Antiphospholipid Syndrome 2.3
mRNA expression profile of Lymphocytes 2.3
AML subtype is a major determinant of the association between prognostic gene expression signatures and their clinical significance. 2.29
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 2.28
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal 2.27
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal [RNA-Seq] 2.27
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 2.27
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 2.27
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 2.26
Long non-coding RNA TYKRIL controls pericyte function and survival in the cardiovascular and central nervous system through regulation of p53 activity and PDGFRß expression 2.25
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 2.24
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 2.24
Analysis of human, chimpanzee, macaque and mouse tissue transcriptomes using Next Generation Sequencing 2.2
Single-cell analysis of adult human ovary using 10X genomics 2.19
RNA-Seq of human induced pluripotent stem cell-derived cardiomyocytes from a cardiomyopathy patient and familial control 2.18
High-resolution comparative analysis of great ape genomes 2.17
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (LNCaP RNA-seq) 2.16
Human Treg NaCl stimulation 2.15
Coordinated control of senescence by lncRNA UCA1 and a novel CAPERα/TBX3 co-repressor 2.14
CRISPR-Cas9 combinatorial KO of epigenetic regulators in human ovarian cancer cells 2.14
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 2.14
Effect of venetoclax, tedizolid, and combination treatment on gene expression in a venetoclax-resistant AML cell line 2.12
Transcriptome-wide analysis of the role of HTLV-1 Tax PBM in T-Cells from infected humanized-mice (hu-Mice) 2.11
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 2.1
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 2.1
RNA-sequencing of fibrolamellar carcinoma (FLC) cell line treated with miR-375 mimic 2.06
RNA-Seq of SLNCR1 over-expression in the melanoma cell line A375 2.04
Transcriptional profiling of CD45RO+CD57+CD4+ T cells 2.04
Genome-wide discovery of human splicing branchpoints [RNAse] 2.02
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist 2.02
PRDM1 inhibits proliferation of human colon cancer organoids 2.01
RNA-seq analysis identifies different transcriptomic types and developmental trajectories of primary melanomas 2.01
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 2.0
Dissecting neural differentiation regulatory networks through epigenetic footprinting 1.99
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 1.98
Global transcriptome analysis in the MYCN-amplified neuroblastoma cell line IMR5-75 upon inducible MYCN-knockdown 1.92
Tyrosine-1 of RNAPII CTD controls global termination of gene transcription in mammals 1.92
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA binding affinities 1.9
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 1.9
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 1.88
RNA deep sequencing analysis of glioma stem cells(GSCs) and non-GSCs 1.88
N6-methyladenosine (m6A) profiling of EndoC-bH1 cell line and RNA seq of Mettl14 knockout mice beta cell 1.88
RNA-sequencing with micro-dissected boundary organoid into anterior, posterior, and boundary regions 1.85
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 1.85
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 1.84
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 1.84
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons 1.84
Expansion, in vivo-ex vivo cycling and genetic manipulation of primary human hepatocytes 1.82
RNA-seq of cells with TET1 knockout 1.82
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 1.82
Transcriptomics profiles of patient-matched normal kidney and ccRCC pairs 1.81
Transcriptomic analysis of inter- and intra-patient variation in human iPSC cardiomyocytes: Platform for precision medicine to predict drug toxicity 1.79
Mechanosensitive ion channel regulates tissue stiffening to promote glioma aggression 1.79
RNA Sequencing of Human iPS derived Cardiomyocytes 1.77
Cerebral Organoids Recapitulate Epigenomic Signatures of the Human Fetal Brain 1.74
Transcriptome profiling in primary human skeletal myotubes with MondoA knockdown 1.74
MondoA Links Muscle Lipid Accumulation and Insulin Resistance Driven by Nutrient Overload 1.74
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 1.72
K562 polyA RNA-Seq 1.72
Splicing and gene expression changes in human mammary epithelial MCF-10A cells expressing SR or SR-like proteins 1.71
Global unleashing of transcription elongation waves in response to genotoxic stress restricts somatic mutation rate 1.71
GATA3 enhances the neurogenic potential of primary human astrocytes after traumatic injury [exp1] 1.68
A RUNX2-mediated Epigenetic Regulation of the Survival of p53 Defective Cancer Cells 1.66
RNA sequencing of human mammary epithelial cells 1.65
Genes encoding cognate receptors for IRI-related recipient cytokines are expressed in donor livers 1.64
Dissecting cell composition and cell-cell interaction network of human disease heart tissue by single-cell sequencing 1.63
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 1.63
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 1.62
Role of COP1 on MAP kinase transcriptional output in gastrointestinal stromal tumor 1.62
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq1] 1.62
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 1.61
Differential gene expressions in the heart of hypertrophic cardiomyopathy patients 1.59
Tracking transcriptional changes in a species-specific manner during experimental hepatoblastoma progression in vivo 1.59
FOXO1 is an oncogenic mediator in AML1-ETO leukemia 1.58
Identifying markers predicting successful graft outcome for clinical translation of hESC-based cell therapy for Parkinson’s disease 1.58
UV_24h_GRO-Seq 1.57
Transcriptome sequencing analysis of BRAF-mutant melanoma metastases. 1.56
RNAseq of quiescent (Q) and stress induced premature senescent (SIPS) fibroblasts treated with plant extract (1201) from Solidago vigaurea subspecies alpestris 1.53
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence [RNA-seq] 1.52
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence 1.52
A novel RAF kinase inhibitor with DFG-out binding mode: high efficacy in BRAF-mutant tumor xenograft models in the absence of normal tissue hyperproliferation 1.52
RNA-seq characterization of downstream effects of upregulating SMN2 via down-regulating PRC2 or blocking the PRC2:SMN-AS1 interaction with a mixmer oligonucleotide 1.5
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [BAV] 1.5
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 1.49
RNA editing in nascent RNA affects pre-mRNA splicing 1.48
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection [RNA-seq] 1.47
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection 1.47
Energy Metabolism during Anchorage-Independence 1.46
Functional Haploid Human Oocytes Generated from Polar Body Genomes 1.42
Functional Haploid Human Oocytes Generated from Polar Body Genomes (RNA-Seq) 1.42
Combinatorial Reprogramming of Estrogen Signaling by the Nuclear Receptor Family 3C 1.41
Transcriptomic profiling of O-GlcNAcylated mRNA-protein complexes by using OG-CLAP in HeLa cells. 1.4
The transcription and translation landscapes during human cytomegalovirus infection reveal novel host-pathogen interactions 1.4
GATA3 enhances the neurogenic potential of primary human astrocytes after traumatic injury [exp2] 1.38
RNA-seq of MCF10A cells and CAF 1.38
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure by siRNA knockdown of Anillin [tpo8] 1.31
Loss of EGFR-DDEF1 signaling in metastatic and unresectable hepatoblastoma 1.28
Modeling Human Cancer-induced Cachexia (Human) 1.27
Gene expression analysis in response to hypoxic pathway inhibition 1.26
Molecular Pathology of adverse local tissue reaction caused by metal-on-metal implants 1.26
Discovering human diabetes-risk gene function with genetics and physiological assays 1.24
PTEN interacts with the transcription machinery on chromatin and regulates RNA polymerase II-mediated transcription.[RNA-seq and ChIP-seq] 1.22
PTEN interacts with the transcription machinery on chromatin and regulates RNA polymerase II-mediated transcription 1.22
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected uterine smooth muscle cells (USMC) 1.2
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 1.19
ELAVL2-regulated transcriptional networks in human neurons link atlernative splicing, autism and human neocortical evolution 1.17
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 1.16
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 1.16
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 1.16
RNA-Seq characterization of human H1-derived NPC differentiation timecourse 1.15
Iron response of HepG2 cells 1.13
Gene expression analysis upon mtDNA depletion [RNA-seq] 1.12
Gene expression analysis upon mtDNA depletion 1.12
RNA-sequencing study of peripheral blood monocytes for chronic periodontitis 1.08
Widespread regulated alternative splicing of single codons accelerates proteome evolution 1.08
Antiviral and anti-inflammatory properties of novel anti-HIV candidate ABX464 promotes specifics RNA splicing while preserving cellular RNA integrity. 1.06
Divergent expression and metabolic functions of human glucuronosyltransferases through alternative splicing 1.04
Characterisation of the myeloid differentiation process of human hematopoietic stem cells 1.0
RNA sequencing of erythroid and granulomonocytic colonies differentiated from transduced bone marrow CD34+ cells expressing U2AF1 S34F mutation, U2AF1 wild-type or empty vector control 1.0
Functional significance of the HIV-1 Tat signature amino acid residues 1.0
Generating Patterned Kidney Organoids for Studying Development and Diseases [bulk RNA-Seq] 0.99
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 0.96
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [TAV] 0.91
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 0.9
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 0.9
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 0.88
YAP and MRTF-A, transcriptional co-activators of RhoA- mediated gene expression, are critical for glioblastoma tumorigenicity 0.87
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy [RNA-Seq] 0.87
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy 0.87
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 0.86
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 0.86
Ribosomal protein RPL26 is the principal target of UFMylation 0.86
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells 0.84
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells (RNA-Seq) 0.84
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 0.83
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 0.83
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 0.82
Human Embryoid Body Transcriptomes Reveal Maturation Differences Influenced by Size and Formation in Custom Microarrays 0.81
Evaluation of the effectiveness of semen collection and sperm purification methods for spermatozoa transcript profiling 0.81
Adaptation of the Kinome Promotes Resistance to BET Bromodomain Inhibitors in Ovarian Cancer 0.81
Transcriptomic insights into human decidual and peripheral blood CD4 T cells 0.79
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML 0.74
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq human] 0.74
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 0.73
Impact of DNA demethylation agents (5-azacytidine or vitamin C) on gene expression in glioblastoma HSR-GBM1 cells 0.72
Induced DNA demethylation, genome instability and transcription 0.72
Effector and regulatory T cells roll at high shear stress by inducible tether and sling formation 0.7
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 0.69
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 0.69
Comparative Analysis of Cas9 Activators Across Multiple Species 0.68
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells 0.67
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells (RNA-seq) 0.67
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 0.65
Effects of Spaceflight on Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Structure and Function 0.65
Primate-specific gene TMEM14B promotes cortical expansion and folding 0.65
Effects of a nutritional supplement in older individuals subject to ten days of complete bed rest. 0.64
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 0.64
Measure transcript integrity using RNA-seq data 0.61
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [RNA-Seq III] 0.58
Networks of cultured iPSC-derived neurons reveal the human synaptic activity-regulated adaptive gene program 0.57
The global transcriptome analysis in the time course of hESC-derived cardiac differentiation 0.55
Dilated cardiomyopathy vs Myocarditis 0.54
eRNA: A graphic user interface-based tool for RNA sequencing data analysis 0.54
eRNA: A graphic user interface-based tool for RNA sequencing data analysis [mRNA-Seq] 0.54
O-glcnAc reprograms cellular energetics 0.54
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. Tested on 5 concentrations. 0.51
RNA-seq of ASXL2 shRNA KD in SKNO-1 cells 0.51
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma 0.5
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma [RNA-seq] 0.5
An integrative analysis of non-coding regulatory DNA variations associated with autism 0.5
An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch Type Alopecia Areata, Totalis and Universalis 0.5
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 0.46
RNA-Seq analysis of human colorectal cancer with liver metastasis 0.43
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 0.42
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.42
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.42
Screening in Human Cardiac Organoids Identifies a Requirement for the Mevalonate Pathway in Cardiomyocyte Proliferation 0.39
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 0.37
Microsatellite expansion RNA visualization, elimination, and reversal of molecular pathology by RNA-targeting Cas9 0.32
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development (HPC-5F RNAseq) 0.31
SQSTM1/p62-directed metabolic reprogramming is essential for normal neurodifferentiation 0.3
single cell RNA-seq from GM12878 (ENCSR673UIY) 0.29
Effect of BET bromodomain inhibition with JQ1 in stressed human derived iPS cardiomyocytes 0.28
BET bromodomain inhibition 0.28
CRISPR-Cas9 based screen for p53-bound enhancers that function in oncogene-induced senescence 0.24
Induction of Cardiomyocyte Proliferation [pz-822_human] 0.23
Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration 0.23
CD161+ Tconv and Treg share transcriptome and display a migratory phenotype which is modified at the inflamed site 0.23
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection 0.23
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection [RNA-seq] 0.23
Combined MEKi (GDC-0973) and WNT (G007-LK) treatment in APC and KRAS mutant HCT-15 cell line 0.23
Gene expression profile of calcified and normal tricuspid aortic valves by RNA sequencing. 0.21
Radiation enhances melanoma response to immunotherapeutic and synergizes with benzodiazepines to promote improved anti-tumor activity 0.21
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 0.2
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity 0.19
A novel tumor-associated myeloid cell population inhibits antigen-specific immune responses in cancer patients 0.19
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 0.18
Concomitant BCORL1 and BRAF mutations in vemurafenib-resistant melanoma cells 0.18
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors [RNA-seq 2] 0.17
Genome-wide DNA hypomethylation and RNA:DNA hybrid accumulation in Aicardi-Goutières syndrome 0.16
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 0.15
RNA-Seq identifies condition-specific biological signatures of ischemia-reperfusion injury in the human kidney 0.15
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration [Microfluidics] 0.15
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 0.14
Aberrant downstream mechanisms following loss of KMT2C and KMT2D in Pancreatic Ductal Adenocarcinoma 0.14
CD133hi, Notchhi, DP (double positive) and DN (double negative) in GBML8 and GBML20, both patient-derived glioblastoma tumorsphere cultures 0.13
Deep RNA sequencing of the human placental transcriptome 0.11
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 rescue] 0.11
Research resource: global identification of estrogen receptor β target genes in triple negative breast cancer cells 0.11
Connexin 32-mediated cell-cell communication is essential for hepatic differentiation from human embryonic stem cells 0.1
Leucegene: AML sequencing (part 6) 0.1
Role of FGFR1 in neuronal devlopment 0.1
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 0.09
HEXIM1 is induced by DHODH inhibition to suppress melanoma [Gro-Seq] 0.08
HEXIM1 is induced by DHODH inhibition to suppress melanoma 0.08
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 0.07
RNA sequencing and pathway analysis identify important pathways involved in hypertrichosis and intellectual disability in patients with Wiedemann-Steiner syndrome 0.07
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) in proliferation, quiescence, senescence and transformed states. 0.06
Human Induced Pluripotent Stem Cells Recapitulate Breast Cancer Patients’ Predilection to Doxorubicin-Induced Cardiotoxicity 0.04
Apoptosis enhancing drugs overcome innate platinum resistance in CA125 negative tumor initiating populations of high grade serous ovarian cancer 0.02
Transcriptome of Primitive Human Hematopoietic Cells: A New Resource to Find hHSC-Specific Genes 0.02
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 0.02
Hepatic transcriptome of pediatric hepatoblastoma. 0.01
Gene expression profiles of ibrutinib-responsive and ibrutinib non-responsive cells in ERBB4 expressing cancer cell lines 0.01
RNA sequencing of hiPSC derived neural crest populations from Familial Dysautonomia patients 0.01
ALS implicated protein TDP-43 sustains levels of STMN2 a mediator of motor neuron growth and repair 0.01
A histone H3.3 Lysine 36 Trimethylation Reader Connects Chromatin to Regulated Pre-mRNA Processing 0.0
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation